How It Works | TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
Lumacaftor stimulated correction of CFTR-dependent Cl − secretion. I sc... | Download Scientific Diagram
Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator - ScienceDirect
Orkambi (lumacaftor/ivacaftor) for the Treatment of Cystic Fibrosis (CF) - Clinical Trials Arena
Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR - Journal of Cystic Fibrosis
Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers - ScienceDirect
Ivacaftor pathway, pharmacokinetics/pharmacodynamics
Therapeutic approaches to CFTR dysfunction: From discovery to drug development - Journal of Cystic Fibrosis
Ivacaftor and lumacaftor Drugs
Ivacaftor and lumacaftor Drugs
Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation. - Abstract - Europe PMC
Profile of lumacaftor/ivacaftor combination: potential in the treatmen | ODRR
Cureus | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
Modulators of CFTR. Updates on clinical development and future directions - ScienceDirect
The different classes of CFTR gene mutations and the mechanisms of... | Download Scientific Diagram
PTI-CH improves the functional rescue of F508del-cystic fibrosis... | Download Scientific Diagram
A minimal helical-hairpin motif provides molecular-level insights into misfolding and pharmacological rescue of CFTR | Communications Biology
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects | Semantic Scholar
Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis - eBioMedicine
Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, deve | DDDT
Mechanism of action of ivacaftor | Download Scientific Diagram
Combination therapy in Phe508del CFTR: how many will be enough?
Orkambi (lumacaftor/ivacaftor) for the Treatment of Cystic Fibrosis (CF) - Clinical Trials Arena
Cystic fibrosis: novel therapies, remaining challenges - Coulthard - 2018 - Journal of Pharmacy Practice and Research - Wiley Online Library
Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation. - Abstract - Europe PMC
Biomolecules | Free Full-Text | Lumacaftor and Matrine: Possible Therapeutic Combination to Counteract the Inflammatory Process in Cystic Fibrosis
